|
Resolve360 is a physical medicine and rehabilitation company that provides evidence-based, personalized rehabilitation programmes for individuals suffering from neuromuscular and musculoskeletal disorders. It has been granted an Indian patent for its proprietary rehabilitation methodology, marking a significant milestone in the evolution of physical medicine and rehabilitation.
The patented methodology introduces a structured, evidence-based framework for treating neuromuscular and musculoskeletal (NMSK) disorders, covering the entire patient journey from prognosis and personalized protocol creation to treatment delivery, monitoring, and long-term recovery. The patent, titled "System and Method for Prognosis, Protocol Creation, Delivery & Execution for Neuromuscular and Musculoskeletal Disorders," was granted by the Patent Office, Government of India in July 2026.
The methodology is the outcome of nearly a decade of clinical learning. The concept was first envisioned in 2016, with Resolve360 being founded in 2019 to develop and refine the approach through continuous clinical practice. After years of research, patient feedback, and protocol optimization, the company filed its patent application in 2024, receiving the grant in 2026. It has treated over thousands of patients and delivered 20+ lakh rehabilitation sessions, helping validate and strengthen the effectiveness of the methodology across a wide range of neuromuscular and musculoskeletal conditions.
While physiotherapy became significantly more accessible through online consultations following the pandemic, rehabilitation practices remain largely fragmented. More importantly, rehabilitation is often approached as an afterthought in the continuum of care rather than as a proven, structured treatment methodology in itself. Resolve360's patented methodology seeks to address this gap by bringing structure, consistency, and clinical rigor to rehabilitation, transforming it from a reactive service into a comprehensive, protocol-driven treatment methodology.
The platform currently serves patients in the United States, the United Kingdom, Australia, the UAE, and other Gulf countries, extending evidence-based rehabilitation to individuals seeking personalized and continuous care regardless of location.
Dr Apoorva Shrivastava, CEO Resolve360 and Inventor of the patented methodology, said, “Every era faces its own health epidemic, and today's epidemic is neuromuscular and musculoskeletal disorders driven by sedentary lifestyles and technology-centric living. Despite advances in healthcare, rehabilitation continues to lack standardized treatment methodologies that ensure consistent outcomes. This patent represents years of clinical learning brought together into a structured rehabilitation framework that focuses on identifying the root cause, delivering customized physical medicine in the right dosage, and guiding patients through complete recovery rather than temporary pain relief."
Looking ahead, Resolve360 is also building AI capabilities to support the future of rehabilitation. The company's growth has also been strengthened through seed funding from Kalaari Capital.
|